News & Events
Press Releases
- December 11, 2009
- ProMetic validates its regulatory pathway for PBI-1402 with the FDA
- December 1, 2009
- ProMetic enters agreement to improve manufacturing process for second-generation biopharmaceutical targeting $1B market
- November 20, 2009
- SaBTO recommends use of P-Capt(R) prion reduction filter to protect children from vCJD blood transmission
- November 13, 2009
- ProMetic reports its Third Quarter 2009 Highlights and Financial Results
- November 10, 2009
- ProMetic announces details of the conference call / webcast for its Third Quarter 2009 financial results
- November 9, 2009
- ProMetic and Halozyme enter into long-term supply agreement
- October 23, 2009
- ProMetic to report results of PBI-1402 data at upcoming Annual Meeting of American Society of Nephrology
- October 5, 2009
- ProMetic obtains controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
- October 1, 2009
- Octapharma provides ProMetic with a $4.5 M advance on a long-term supply agreement
- September 24, 2009
- ProMetic signs long-term supply agreement with major global pharmaceutical company and secures $8.9 M initial order for Mimetic Ligand™ product
- September 3, 2009
- ProMetic to present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference
- August 24, 2009
- ProMetic continues to access capital and reduce expenditures
- August 5, 2009
- ProMetic reports its Second Quarter 2009 highlights and financial results
- August 4, 2009
- ProMetic announces date for Second Quarter 2009 financial results and conference call
- May 14, 2009
- ProMetic reports its First Quarter 2009 highlights and financial results
- May 7, 2009
- ProMetic reports highlights of its Annual and Special Meeting of Shareholders
- April 30, 2009
- Sumitomo to act as advisor to ProMetic for Japanese market
- April 27, 2009
- ProMetic provides information for its Annual and Special Meeting of Shareholders
- March 31, 2009
- ProMetic announces highlights and year end financials for 2008
- March 3, 2009
- HemCon Medical Technologies Inc. and ProMetic BioSciences Ltd announce collaborative development agreement